This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Sunday, April 17 | 4:00PM - 8:00PM
Arrival and Registration
Room: La Jolla Prefunction


Sunday, April 17 | 6:00PM - 8:00PM
Welcome Mixer
Room: La Jolla Prefunction
No registration fees are used to fund alcohol served at this function.

Monday, April 18 | 7:30AM - 8:30AM
Breakfast
Room: La Jolla/Pacifica


Monday, April 18 | 8:30AM - 9:30AM
Welcome and Keynote Address
Room: La Jolla Ballroom

Speaker 1 of 3
* Matthias H. Tschöp, Helmholtz Zentrum München and Technische Universität München, Germany

Monday, April 18 | 8:30AM - 9:30AM
Welcome and Keynote Address
Room: La Jolla Ballroom

Speaker 2 of 3
* Nancy A. Thornberry, Kallyope, Inc., USA

Monday, April 18 | 8:30AM - 9:30AM
Welcome and Keynote Address
Room: La Jolla Ballroom

Speaker 3 of 3
Joseph L. Goldstein, University of Texas Southwestern Medical Center, USA
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins

Monday, April 18 | 9:30AM - 11:45AM
Identification of Breakthrough Therapies for the Treatment o
f Diabetes and Obesity: Challenges and Opportunities

Room: La Jolla Ballroom

Speaker 1 of 7
* Eleftheria Maratos-Flier, Beth Israel Deaconess Medical Center, USA

Monday, April 18 | 9:30AM - 11:45AM
Identification of Breakthrough Therapies for the Treatment o
f Diabetes and Obesity: Challenges and Opportunities

Room: La Jolla Ballroom

Speaker 2 of 7
* Jeffrey Flier, Harvard University, USA

Monday, April 18 | 9:30AM - 11:45AM
Identification of Breakthrough Therapies for the Treatment o
f Diabetes and Obesity: Challenges and Opportunities

Room: La Jolla Ballroom

Speaker 3 of 7
Philip Home, Newcastle University, UK
Developing New Therapies for the Management of Type 2 Diabetes

Monday, April 18 | 9:30AM - 11:45AM
Identification of Breakthrough Therapies for the Treatment o
f Diabetes and Obesity: Challenges and Opportunities

Room: La Jolla Ballroom

Speaker 4 of 7
Steven R. Smith, AdventHealth, USA
Current State of Therapy in Treatment of Obesity

Monday, April 18 | 9:30AM - 11:45AM
Identification of Breakthrough Therapies for the Treatment o
f Diabetes and Obesity: Challenges and Opportunities

Room: La Jolla Ballroom

Speaker 5 of 7
Alan Moses, Novo Nordisk, Denmark
Negotiating Late-Stage Hurdles on the Path from Molecule to Medicine

Monday, April 18 | 9:30AM - 11:45AM
Identification of Breakthrough Therapies for the Treatment o
f Diabetes and Obesity: Challenges and Opportunities

Room: La Jolla Ballroom

Speaker 6 of 7
Marcus Hompesch, ProSciento, Inc., USA
Short Talk: Translational Metabolic Medicine: An Early Phase Clinical Research Perspective

Monday, April 18 | 9:30AM - 11:45AM
Identification of Breakthrough Therapies for the Treatment o
f Diabetes and Obesity: Challenges and Opportunities

Room: La Jolla Ballroom

Speaker 7 of 7
Francois Briand, Physiogenex, France
Short Talk: Journal of Lipid Research Lectureship Junior Investigator Award: Empagliflozin Moderately Increases LDL-Cholesterol Levels through Reduced LDL Catabolism while it Increases Slightly the Reverse Cholesterol Transport in Hamsters

Monday, April 18 | 10:00AM - 10:15AM
Coffee Break
Room: La Jolla Prefunction


Monday, April 18 | 11:45AM - 2:30PM
On Own for Lunch


Monday, April 18 | 11:45AM - 1:00PM
Poster Setup
Room: Pacifica Ballroom


Monday, April 18 | 1:00PM - 10:00PM
Poster Viewing
Room: Pacifica Ballroom


Monday, April 18 | 2:30PM - 4:00PM
Panel: Perspectives on Future Treatment of Metabolic Disease
s and Remaining Unmet Needs
Room: La Jolla Ballroom

Speaker 1 of 5
* Nancy A. Thornberry, Kallyope, Inc., USA

Monday, April 18 | 2:30PM - 4:00PM
Panel: Perspectives on Future Treatment of Metabolic Disease
s and Remaining Unmet Needs
Room: La Jolla Ballroom

Speaker 2 of 5
Philip Home, Newcastle University, UK

Monday, April 18 | 2:30PM - 4:00PM
Panel: Perspectives on Future Treatment of Metabolic Disease
s and Remaining Unmet Needs
Room: La Jolla Ballroom

Speaker 3 of 5
Robert Henry, University of California San Diego/VA Healthcare System/San Diego, USA

Monday, April 18 | 2:30PM - 4:00PM
Panel: Perspectives on Future Treatment of Metabolic Disease
s and Remaining Unmet Needs
Room: La Jolla Ballroom

Speaker 4 of 5
Philip J. Larsen, Bayer Pharmaceuticals, Germany

Monday, April 18 | 2:30PM - 4:00PM
Panel: Perspectives on Future Treatment of Metabolic Disease
s and Remaining Unmet Needs
Room: La Jolla Ballroom

Speaker 5 of 5
Alan Moses, Novo Nordisk, Denmark

Monday, April 18 | 4:00PM - 4:30PM
Coffee Available
Room: La Jolla Prefunction


Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 1 of 9
* Bei B. Zhang, Pfizer Inc., USA

Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 2 of 9
* Daniel Porte Jr., University of California, San Diego, USA

Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 3 of 9
Philip J. Larsen, Bayer Pharmaceuticals, Germany
Antihyperglycemic and Weight Loss Effects of a Novel Dual GLP1R/GCGR Agonist, SAR425899, in Obese People with Type 2 Diabetes

Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 4 of 9
David E. Moller, Eli Lilly and Company, USA
Combinatorial Approaches to Achieve Metabolic Control

Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 5 of 9
Lars Fogh Iversen, Novo Nordisk A/S, Denmark
Oral Protein and Peptide Delivery in Diabetes

Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 6 of 9
Keith M. Gottesdiener, Rhythm Pharmaceuticals, USA
Short Talk: Setmelanotide, A New Melanocortin-4 Receptor (MC4R) Peptide Agonist being studied in Patients with Deficiencies in the MC4R Pathway

Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 7 of 9
Peter Kuehnen, Charité – Universitätsmedizin Berlin, Germany
Short Talk: Successful Therapy of Extreme Obesity in two POMC Deficient Patients with the Melanocortin-4 Receptor Agonist Setmelanotide

Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 8 of 9
Weiyi Chen, Monash University, Australia
Short Talk: Alpha-Melanocyte Stimulating Hormone Regulates Glucose Homeostasis via Melanocortin-5 Receptor Expressed in Skeletal Muscle

Monday, April 18 | 4:30PM - 7:00PM
New Therapeutics: Late-Breaking Clinical Data
Room: La Jolla Ballroom
The organizers propose to query leaders in pharma and biotech to find out what novel and transformative clinical data will be available for presentation at meeting time. We propose a latebreaking session to ensure the most exciting, recent results are presented. Speakers will be selected based on recent developments in drug discovery worldwide and all attempts will be made to include women and minorities. The organizers would like maximal flexibility in this session to ensure a strong program. Potential short and long topics and speakers/institutes include the following:
Speaker 9 of 9
Thomas E. Hughes, Zafgen, Inc, USA
Short Talk: MetAP2 Inhibition as a Therapeutic Approach in Severe and Complicated Obesity

Monday, April 18 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: La Jolla/Pacifica
No registration fees are used to fund alcohol served at this function.

Monday, April 18 | 7:30PM - 10:00PM
Poster Session 1
Room: Pacifica Ballroom


Tuesday, April 19 | 7:30AM - 8:30AM
Breakfast
Room: La Jolla/Pacifica


Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 1 of 9
* Carrie Haskell-Luevano, University of Minnesota, USA

Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 2 of 9
* Simeon Taylor, University of Maryland School of Medicine, USA

Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 3 of 9
Richard D. DiMarchi, Indiana University and Novo Nordisk, USA
New Insulin Analogs for the Treatment of Insulin-Dependent Diabetes

Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 4 of 9
Aaron Kowalski, Juvenile Diabetes Research Foundation International, USA
Utilizing a Diabetes Scorecard to Guide New Therapeutic Research and Development

Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 5 of 9
Timothy Kieffer, University of British Columbia, Canada
Treating Diabetes with Differentiated Pluripotent Stem Cells

Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 6 of 9
Matthias G. von Herrath, Novo Nordisk and La Jolla Institute for Allergy and Immunology, USA
Pathogenesis and New Treatment Options for Human Type 1 Diabetes

Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 7 of 9
Michael C. Lawrence, Walter and Eliza Hall Institute of Medical Research, Australia
Short Talk: Structural Analysis of an Insulin Receptor Agonist Interacting with the Receptor's Ectodomain

Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 8 of 9
Carolin Daniel, Helmholtz Zentrum Muenchen, Germany
Short Talk: Novel Type 1 Diabetes Vaccine Candidates Promote Human Foxp3+Treg Induction in Humanized Mice in vivo

Tuesday, April 19 | 8:30AM - 11:30AM
Novel Insulins and Insulin Action
Room: La Jolla Ballroom

Speaker 9 of 9
Anne Fougerat, CHU Sainte Justine Research Centre, Canada
Short Talk: Neuraminidase 1 Positively Regulates Insulin Signaling

Tuesday, April 19 | 10:00AM - 10:15AM
Coffee Break
Room: La Jolla Prefunction


Tuesday, April 19 | 11:30AM - 2:30PM
On Own for Lunch


Tuesday, April 19 | 11:30AM - 1:00PM
Poster Setup
Room: Pacifica Ballroom


Tuesday, April 19 | 1:00PM - 10:00PM
Poster Viewing
Room: Pacifica Ballroom


Tuesday, April 19 | 2:30PM - 4:00PM
Workshop: Sponsored by Janssen Research and Development, LLC
.
Room: La Jolla Ballroom

Speaker 1 of 8
* Annette Schürmann, German Institute of Human Nutrition Potsdam-Rehbruekce, Germany

Tuesday, April 19 | 2:30PM - 4:00PM
Workshop: Sponsored by Janssen Research and Development, LLC
.
Room: La Jolla Ballroom

Speaker 2 of 8
* Michael A. Cowley, Monash University, Australia

Tuesday, April 19 | 2:30PM - 4:00PM
Workshop: Sponsored by Janssen Research and Development, LLC
.
Room: La Jolla Ballroom

Speaker 3 of 8
Peter J. Havel, University of California, Davis, USA
The UC Davis Type-2 Diabetes Rat: An Improved Rodent Model for Evaluating New Therapies for the Prevention and Treatment of Type-2 Diabetes Mellitus

Tuesday, April 19 | 2:30PM - 4:00PM
Workshop: Sponsored by Janssen Research and Development, LLC
.
Room: La Jolla Ballroom

Speaker 4 of 8
Tommaso Poggioli, Harvard Medical School, USA
Exogenous GDF11 Improves Insulin Sensitivity and Glucose Tolerance in Aging Mice on High Fat Diet

Tuesday, April 19 | 2:30PM - 4:00PM
Workshop: Sponsored by Janssen Research and Development, LLC
.
Room: La Jolla Ballroom

Speaker 5 of 8
Victor Shengkan Jin, Rutgers University, USA
Niclosamide Ethanolamine–Induced Mild Mitochondrial Uncoupling Improves Diabetic Symptoms in Mice

Tuesday, April 19 | 2:30PM - 4:00PM
Workshop: Sponsored by Janssen Research and Development, LLC
.
Room: La Jolla Ballroom

Speaker 6 of 8
Daniel Lindén, AstraZeneca, Sweden
Targeting Foxo1 using cEt Antisense Oligonucleotides Improves Glucose Homeostasis in db/db and Alloxan-Induced Diabetic Mice

Tuesday, April 19 | 2:30PM - 4:00PM
Workshop: Sponsored by Janssen Research and Development, LLC
.
Room: La Jolla Ballroom

Speaker 7 of 8
S.R. Murthy Madiraju, Montreal Diabetes Research Center, CR-CHUM, Canada
Identification of a Mammalian Glycerol-3-Phosphate Phosphatase: Role in Metabolism and Signaling in Pancreatic Beta–Cells and Hepatocytes

Tuesday, April 19 | 2:30PM - 4:00PM
Workshop: Sponsored by Janssen Research and Development, LLC
.
Room: La Jolla Ballroom

Speaker 8 of 8
Andreas Stahl, University of California, Berkeley, USA
Engineering Brown Adipose Tissue

Tuesday, April 19 | 4:00PM - 4:30PM
Coffee Available
Room: La Jolla Prefunction


Tuesday, April 19 | 4:30PM - 7:00PM
Emerging Areas in Drug Discovery
Room: La Jolla Ballroom

Speaker 1 of 7
* Ana Domingos, University of Oxford, UK

Tuesday, April 19 | 4:30PM - 7:00PM
Emerging Areas in Drug Discovery
Room: La Jolla Ballroom

Speaker 2 of 7
* Edward A. Dennis, University of California, San Diego, USA

Tuesday, April 19 | 4:30PM - 7:00PM
Emerging Areas in Drug Discovery
Room: La Jolla Ballroom

Speaker 3 of 7
Jeffrey M. Friedman, Rockefeller University, USA
CNS Control of Metabolism: New Opportunities

Tuesday, April 19 | 4:30PM - 7:00PM
Emerging Areas in Drug Discovery
Room: La Jolla Ballroom

Speaker 4 of 7
Markus Stoffel, ETH Zürich, Switzerland
Discovery of New RNA-Based Therapeutics for the Treatment of Metabolic Diseases

Tuesday, April 19 | 4:30PM - 7:00PM
Emerging Areas in Drug Discovery
Room: La Jolla Ballroom

Speaker 5 of 7
Umut Ozcan, Harvard Medical School, USA
Small Molecule Leptin Sensitizers For Treatment of Obesity

Tuesday, April 19 | 4:30PM - 7:00PM
Emerging Areas in Drug Discovery
Room: La Jolla Ballroom

Speaker 6 of 7
Barbara B. Kahn, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Journal of Lipid Research Lectureship Introduced by JLR Editor-in-Chief, Edward A. Dennis: The Role of Endogenous Lipids in Metabolic Diseases

Tuesday, April 19 | 4:30PM - 7:00PM
Emerging Areas in Drug Discovery
Room: La Jolla Ballroom

Speaker 7 of 7
Junichiro Sonoda, Regeneron Pharmaceuticals, Inc., USA
Short Talk: Endopeptidase FAP Cleaves and Inactivates FGF21

Tuesday, April 19 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: La Jolla/Pacifica
No registration fees are used to fund alcohol served at this function.

Tuesday, April 19 | 7:30PM - 10:00PM
Poster Session 2
Room: Pacifica Ballroom


Wednesday, April 20 | 7:30AM - 8:30AM
Breakfast
Room: La Jolla/Pacifica


Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 1 of 9
* Birgitte Andersen, Novo Nordisk, Denmark

Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 2 of 9
* Matthias Blüher, University of Leipzig, Germany

Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 3 of 9
Thue W. Schwartz, University of Copenhagen, Denmark
Metabolite versus Hormone Receptors - Playing on the Full Enteroendocrine and Pancreatic Orchestra versus Single Instruments

Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 4 of 9
Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute, Canada
New Therapeutic Opportunities in Gut Biology: Balancing Risks and Benefits

Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 5 of 9
Matthias H. Tschöp, Helmholtz Zentrum München and Technische Universität München, Germany
Novel Combination Therapeutics for Diabetes and Obesity

Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 6 of 9
Michael W. Schwartz, University of Washington, USA
Targeting the Brain to Induce Diabetes Remission

Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 7 of 9
Maria Carmen Valcarce Lopez, vTv Therapeutics LLC, USA
Short Talk: Oral Small Molecule GLP-1 Receptor (GLP-1R) Agonists for Type 2 Diabetes (T2DM) with Negligible Nausea and Vomiting

Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 8 of 9
Sofiya Gancheva, German Diabetes Center, Germany
Short Talk: Lack of an Effect of Non-Invasive Vagus Nerve Stimulation on Endogenous Glucose Production and Energy Metabolism in Healthy Humans

Wednesday, April 20 | 8:30AM - 11:30AM
New Therapeutics in Gut Biology
Room: La Jolla Ballroom

Speaker 9 of 9
Gary Deng, Eli Lilly and Company, USA
Short Talk: Pharmacological Inhibition of PDE4 Mediates Pleiotropic Metabolic Benefits in Diet-Induced Obese Mice and Type 2 Diabetes Patients

Wednesday, April 20 | 10:00AM - 10:15AM
Coffee Break
Room: La Jolla Prefunction


Wednesday, April 20 | 11:30AM - 2:30PM
On Own for Lunch


Wednesday, April 20 | 2:30PM - 4:00PM
Panel: Emerging Models for Non-Conventional Approaches to Dr
ug Discovery with an Emphasis on Partnerships
Room: La Jolla Ballroom

Speaker 1 of 5
* Alain Baron, Elcelyx Thereapeutics Inc., USA

Wednesday, April 20 | 2:30PM - 4:00PM
Panel: Emerging Models for Non-Conventional Approaches to Dr
ug Discovery with an Emphasis on Partnerships
Room: La Jolla Ballroom

Speaker 2 of 5
Jerrold M. Olefsky, University of California, San Diego, USA

Wednesday, April 20 | 2:30PM - 4:00PM
Panel: Emerging Models for Non-Conventional Approaches to Dr
ug Discovery with an Emphasis on Partnerships
Room: La Jolla Ballroom

Speaker 3 of 5
Mark D. Erion, Janssen Pharmaceuticals, USA

Wednesday, April 20 | 2:30PM - 4:00PM
Panel: Emerging Models for Non-Conventional Approaches to Dr
ug Discovery with an Emphasis on Partnerships
Room: La Jolla Ballroom

Speaker 4 of 5
Aaron Kowalski, Juvenile Diabetes Research Foundation International, USA

Wednesday, April 20 | 2:30PM - 4:00PM
Panel: Emerging Models for Non-Conventional Approaches to Dr
ug Discovery with an Emphasis on Partnerships
Room: La Jolla Ballroom

Speaker 5 of 5
Steven R. Smith, AdventHealth, USA

Wednesday, April 20 | 4:00PM - 4:30PM
Coffee Available
Room: La Jolla Prefunction


Wednesday, April 20 | 4:30PM - 6:45PM
New Target Discovery
Room: La Jolla Ballroom

Speaker 1 of 8
* Effie Tzameli, Pfizer, USA

Wednesday, April 20 | 4:30PM - 6:45PM
New Target Discovery
Room: La Jolla Ballroom

Speaker 2 of 8
* Martin Hrabé de Angelis, Helmholtz Zentrum München and Technische Universität München, Germany

Wednesday, April 20 | 4:30PM - 6:45PM
New Target Discovery
Room: La Jolla Ballroom

Speaker 3 of 8
Kevin L. Grove, Novo Nordisk, USA
Utility of Non-Human Primates for New Target Validation

Wednesday, April 20 | 4:30PM - 6:45PM
New Target Discovery
Room: La Jolla Ballroom

Speaker 4 of 8
Hui Tian, NGM Biopharma, USA
Identification of Novel Mediators of the Beneficial Metabolic Effects of Gastric Bypass

Wednesday, April 20 | 4:30PM - 6:45PM
New Target Discovery
Room: La Jolla Ballroom

Speaker 5 of 8
Arun Sharma, MedImmune, USA
Short Talk: Neurturin Prevents Hyperglycemia in Zucker Diabetic Fatty Rats via a Mechanism Distinct from GLP-1 Receptor Agonists

Wednesday, April 20 | 4:30PM - 6:45PM
New Target Discovery
Room: La Jolla Ballroom

Speaker 6 of 8
Katrin J. Svensson, Stanford University, USA
Short Talk: A Secreted Slit2 Fragment Regulates Adipose Tissue Thermogenesis and Metabolic Function

Wednesday, April 20 | 4:30PM - 6:45PM
New Target Discovery
Room: La Jolla Ballroom

Speaker 7 of 8
Adriano Maida, Helmholtz Zentrum Munich, Germany
Short Talk: Hepatic Transforming Growth Factor Beta-Like Stimulated Clone 22 D4 (TSC22D4) Controls Systemic Insulin Resistance and Type 2 Diabetes

Wednesday, April 20 | 4:30PM - 6:45PM
New Target Discovery
Room: La Jolla Ballroom

Speaker 8 of 8
Ronald M. Evans, HHMI/The Salk Institute, USA
Nuclear Receptors: Feast, Famine and Physiology


Wednesday, April 20 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions
Room: La Jolla Ballroom

Speaker 1 of 1
* Richard D. DiMarchi, Indiana University and Novo Nordisk, USA

Wednesday, April 20 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: La Jolla/Pacifica
No registration fees are used to fund alcohol served at this function.

Wednesday, April 20 | 8:00PM - 11:00PM
Entertainment
Room: Pacifica Ballroom
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Wednesday, April 20 | 8:00PM - 11:00PM
Cash Bar
Room: La Jolla/Pacifica


Thursday, April 21 | 10:25AM - 10:25AM
Departure


*Session Chair.

No content found

No content found

No content found